X-group (possible homology)

1128 LYR protein

Ligands and drugs

1,058
Member domains
540
with ligand contacts (≤ 4 Å)
51.0% of members
345
with DrugDomain annotations
32.6% of members
76
with a DrugBank compound
7.2% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

26
Proteins with classified ligands
2
Superclasses bound (of 23)
2.0
Superclasses per 20 proteins
narrower than 99% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds012.60q < 0.0001
Homogeneous non-metal compounds05.50q = 6.7e-3
Nucleosides, nucleotides, and analogues07.10q = 1.4e-3
Organic oxygen compounds05.10q = 0.01
Organic acids and derivatives254.06.30×not tested
Lipids and lipid-like molecules62.92.10×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB03429CDLTetrastearoyl cardiolipin53
DB03912PNSD-pantetheine 4'-phosphate14
DB00974EDTEdetic acid5
DB02777PLCDiundecyl Phosphatidyl Choline4

Most frequently bound compounds

PDB ligandNameDomains in contact
EHZ~{S}-[2-[3-[[(2~{R})-3,3-dimethyl-2-oxidanyl-4-phosphonooxy-butanoyl]amino]propanoylamino]ethyl] (3~{S})-3-oxidanyltetradecanethioate191
8Q1S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate185
ZMPS-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] tetradecanethioate142
PLCDIUNDECYL PHOSPHATIDYL CHOLINE20
3PE1,2-Distearoyl-sn-glycerophosphoethanolamine17
PNS4'-PHOSPHOPANTETHEINE16
CDLCARDIOLIPIN7
EDT{[-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-CARBOXYMETHYL-AMINO}-ACETIC ACID6
PM8S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) DECANETHIOATE6
PC7(7S)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE2